Please find the full release here.

The company anticipates continued strong performance, with significant revenue and EBITDA growth for the first half of FY25, compared to the prior corresponding period.

Please find the full announcement here.

The revenue growth of $16.2 million was driven by a combination of organic growth from existing operations of $7.0 million or 17% growth, together with revenues from the two acquisitions made through the year, being Teknocorp (purchased 27 November 2023) with $6.5 million revenue and Amentco (purchased 1 May 2024) with $2.7 million revenue.

The combination of double digit organic revenue growth and the successful integration of the two acquired businesses into the group provides for record FY24 results and sets a platform for future growth and success.

Please find the complete document here.

The revenue growth of $16.2 million was driven by a combination of organic growth from existing operations of $7.0 million or 17% growth, together with revenues from the two acquisitions made through the year, being Teknocorp (purchased 27 November 2023) with $6.5 million revenue and Amentco (purchased 1 May 2024) with $2.7 million revenue.

Please find the full media release here.

The full announcement may be found here.

Mount Elizabeth Hospital, a flagship of Parkway Hospitals Singapore, stands as a cornerstone of Asia’s foremost integrated private healthcare provider, spanning Malaysia, Singapore, India, Greater China, and Brunei. With a reputation for excellence, MEH has emerged as one of Asia’s largest private hospitals and boasts an unparalleled concentration of specialized medical professionals, including cardiologists, cardiac surgeons, neurologists, and neurosurgeons.

Please find the full press release here.